CHRNA7 and Alzheimer disease: Moreover, neuroinflammation, an important risk factor for AD and non-AD dementia [28], could be modulated by the loss of the nicotinic phenotype, mainly related to α7 nAChRs expressed in neuronal and non-neuronal cells, which mediate the cholinergic anti-inflammatory pathway (CAIP) [29].